abstract |
The present invention relates to nucleic acids containing one or more adaptive mutations, and HCV replicon enhancing cells. Adaptive mutations are mutations that enhance HCV replicon activity. HCV replicon-enhancing cells are cells that have an enhanced ability to maintain HCV replicons. |